The Ontario Naloxone Program (ONP) and META:PHI have prepared a bulletin on the importance of making
READ MOREIn order to improve the quality and credibility of our materials, META:PHI would like to assemble a
READ MOREThese recommendations for the management of alcohol-related emergency department (ED) presentations were developed by a group of people with professional and/or experiential expertise of alcohol use. Part of Toolkit for Alcohol-Related Presentations to the Emergency Department Version date: 15 December 2023
Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT). Authors: Karan Cheema, Meldon Kahan, Jason Rodgers, Ashley Smoke, Suzanne Turner, Jennifer Wyman, Maria Zhang Reviewers: Lisa Bromley, Katie Dunham, Caryn Green, Janelle Hannon, Christina Henry, Cassandra Huck, Laura Jones, Kate Lazier, Andrew McLeod, Charlotte Munro, Patrick Nowak, Lori Regenstreif, Michael Roach, Elizabeth Shouldice, Anita Srivastava Design: Brent Logan Version date: 01 November 2023
A plain-language summary of the document “Recommendations for the use of slow-release oral morphine as opioid agonist therapy”, intended for patients interested in learning about slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT). Authors: Karan Cheema, Meldon Kahan, Jason Rodgers, Ashley Smoke, Suzanne Turner, Jennifer Wyman, Maria Zhang Reviewers: Lisa Bromley, Katie Dunham, Caryn Green, Janelle Hannon, Christina Henry, Cassandra Huck, Laura Jones, Kate Lazier, Andrew McLeod, Charlotte Munro, Patrick Nowak, Lori Regenstreif, Michael Roach, Elizabeth Shouldice, Anita Srivastava Design: Brent Logan Version date: 01 November 2023
A tool for patients to use with their health care providers to help them decide what opioid agonist therapy (OAT) option would be best for them: sublingual buprenorphine (Suboxone), depot buprenorphine (Sublocade), methadone, or slow-release oral morphine (Kadian). Authors: Karan Cheema, Meldon Kahan, Jason Rodgers, Ashley Smoke, Suzanne Turner, Jennifer Wyman, Maria Zhang Reviewers: Lisa Bromley, Katie Dunham, Caryn Green, Janelle Hannon, Christina Henry, Cassandra Huck, Laura Jones, Kate Lazier, Andrew McLeod, Charlotte Munro, Patrick Nowak, Lori Regenstreif, Michael Roach, Elizabeth Shouldice, Anita Srivastava Design: Brent Logan Version date: 01 November 2023
76 Grenville St.
Toronto, ON M5S 1B2
416-323-6400 x7511
Kate Hardy
Network Director
Ontario Ministry of Health
Program Sponsor